Indication
Metastatic breast carcinoma
Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics. Read more about Metastatic breast carcinoma
244 drugs 124 manufacturers
Drugs that treat it
Common Metastatic breast carcinoma therapies.
DOXORUBICIN HCL
GEMCITABINE HCL
FLUOROURACIL
CAPECITABINE
GEMCITABINE HCL
GEMCITABINE HCL
DOCETAXEL
DOCETAXEL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMetastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics.
Dissemination occurs when neoplastic mammary epithelial cells invade the bloodstream or lymphatic vessels and establish secondary lesions in distant anatomical sites, most commonly the skeletal system, liver, lungs, brain, and distant lymph nodes.
Primarily affecting adult females but also occurring rarely in males, the condition is clinically categorized by specific molecular biomarkers—including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status—which govern disease kinetics, distant organ tropism, and systemic therapeutic responsiveness.
- lbbc.org
Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics
- cancer.gov
Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics Primarily affecting adult females but also occurring rarely in males, the condition is clinically categorized by specific molecular biomarkers—including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status—which govern disea...
- medlineplus.gov
Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics Primarily affecting adult females but also occurring rarely in males, the condition is clinically categorized by specific molecular biomarkers—including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status—which govern disea...
- medlineplus.gov
Metastatic breast carcinoma, also designated as stage IV breast cancer, is an advanced malignancy originating from epithelial tissues within the breast ducts or lobules that has disseminated beyond local and regional lymphatics
- cancer.gov
Dissemination occurs when neoplastic mammary epithelial cells invade the bloodstream or lymphatic vessels and establish secondary lesions in distant anatomical sites, most commonly the skeletal system, liver, lungs, brain, and distant lymph nodes
- nih.gov
Dissemination occurs when neoplastic mammary epithelial cells invade the bloodstream or lymphatic vessels and establish secondary lesions in distant anatomical sites, most commonly the skeletal system, liver, lungs, brain, and distant lymph nodes
- cancersupportcommunity.org
Dissemination occurs when neoplastic mammary epithelial cells invade the bloodstream or lymphatic vessels and establish secondary lesions in distant anatomical sites, most commonly the skeletal system, liver, lungs, brain, and distant lymph nodes Primarily affecting adult females but also occurring rarely in males, the condition is clinically categorized by specific molecular biomarkers—including estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) status...
Personalize your experience
Follow Metastatic breast carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.